WKN: | A1C9RN |
ISIN: | US53220K5048 |
Land: | USA |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Pharma |
Weshalb die Ligand Pharmaceuticals-Aktie
ein B-Rating hat,
erfahren Sie im Performance-Check
vom 11. September 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2013 | 9,93 | 24,03 | 141,99% |
2 | 2015 | 26,33 | 61,97 | 135,36% |
3 | 2003 | 20,20 | 44,90 | 122,28% |
4 | 2012 | 5,55 | 9,93 | 78,92% |
5 | 2021 | 49,75 | 88,83 | 78,55% |
6 | 2024 | 64,50 | 104,00 | 61,24% |
7 | 2001 | 53,13 | 74,83 | 40,84% |
8 | 2011 | 4,16 | 5,55 | 33,41% |
9 | 2025 | 104,00 | 138,00 | 32,69% |
10 | 1999 | 34,82 | 44,90 | 28,95% |
11 | 2000 | 44,90 | 53,13 | 18,33% |
12 | 2017 | 61,36 | 70,78 | 15,35% |
13 | 2014 | 24,03 | 26,33 | 9,57% |
14 | 2005 | 31,88 | 34,01 | 6,68% |
15 | 2018 | 70,78 | 73,96 | 4,49% |
16 | 2023 | 62,76 | 64,50 | 2,77% |
17 | 2016 | 61,97 | 61,36 | -0,98% |
18 | 2009 | 6,77 | 6,02 | -11,08% |
19 | 2006 | 34,01 | 30,23 | -11,11% |
20 | 2020 | 59,24 | 49,75 | -16,02% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2002 | 74,83 | 20,20 | -73,01% |
2 | 2007 | 30,23 | 12,20 | -59,64% |
3 | 2008 | 12,20 | 6,77 | -44,51% |
4 | 2010 | 6,02 | 4,16 | -30,90% |
5 | 2022 | 88,83 | 62,76 | -29,35% |
6 | 2004 | 44,90 | 31,88 | -29,00% |
7 | 2019 | 73,96 | 59,24 | -19,90% |
8 | 2020 | 59,24 | 49,75 | -16,02% |
9 | 2006 | 34,01 | 30,23 | -11,11% |
10 | 2009 | 6,77 | 6,02 | -11,08% |
11 | 2016 | 61,97 | 61,36 | -0,98% |
12 | 2023 | 62,76 | 64,50 | 2,77% |
13 | 2018 | 70,78 | 73,96 | 4,49% |
14 | 2005 | 31,88 | 34,01 | 6,68% |
15 | 2014 | 24,03 | 26,33 | 9,57% |
16 | 2017 | 61,36 | 70,78 | 15,35% |
17 | 2000 | 44,90 | 53,13 | 18,33% |
18 | 1999 | 34,82 | 44,90 | 28,95% |
19 | 2025 | 104,00 | 138,00 | 32,69% |
20 | 2011 | 4,16 | 5,55 | 33,41% |